Calcium channel blockers: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
(Add verified PubMed references (PMIDs 21896151)) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 27: | Line 27: | ||
==Doses:== | ==Doses:== | ||
*[[Nifedipine]] | *[[Nifedipine]]<ref>Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011 Sep;13(9):687-9. PMID 21896151</ref> | ||
**10- | **10-30mg tid (Adalat CC: 30-90mg qD) | ||
*[[Diltiazem]] | *[[Diltiazem]] | ||
**60-120 TID (CD: 180- | **60-120 TID (CD: 180-360mg qD) | ||
*[[Verapamil]]: 80- 120mg TID | *[[Verapamil]]: 80- 120mg TID | ||
*[[Bepiridil]]: 200-400mg QD | *[[Bepiridil]]: 200-400mg QD | ||
| Line 41: | Line 41: | ||
==See Also== | ==See Also== | ||
*[[Calcium Channel Blocker Toxicity]] | *[[Calcium Channel Blocker Toxicity]] | ||
==References== | |||
<references/> | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 11:00, 22 March 2026
| Ca Blocker | BP/SVR | HR | SA/AV | CF | ION |
| Nifedipine | +++ | + | - | + | - |
| Diltiazem | ++ | - | + | + | - |
| Verapamil | + | -- | ++ | + | - |
| Bepiridil | +++ | (-) | min. | +++ | - |
| Amlodipine | +++ | + | + | ||
| Felodipine | + | + | |||
| Nicardipine | |||||
| Clevidipine |
CF = coronary flow, ION = ionotropy, SA/AV = nodes
Doses:
- Nifedipine[1]
- 10-30mg tid (Adalat CC: 30-90mg qD)
- Diltiazem
- 60-120 TID (CD: 180-360mg qD)
- Verapamil: 80- 120mg TID
- Bepiridil: 200-400mg QD
- Amlodipine: 2.5- 20mg (10) qD
- Nicardipine
- PO: 20-40mg q8hr, or 30-60mg (extended release) q12hr
- IV: 5mg/hr by slow infusion (50ml/hr), titrate to maximum of 30mg/hr, then maintenance of 2.0 - 15.5mg/hr
- Clevidipine: 1-2 mg IV per hour
See Also
References
- ↑ Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011 Sep;13(9):687-9. PMID 21896151